Thank you for waiting, and welcome to the Interface Third Quarter 2025 Earnings Conference Call. I will now hand the call over to Christine Needles from Global Communications. Please proceed.

Good morning, and welcome to Interface's conference call regarding third quarter 2025 results, hosted by Laurel Hurd, CEO; and Bruce Hausmann, CFO. During today's conference call, any management comments regarding Interface's business, which are not historical information, are forward-looking statements within the meaning of federal securities laws. Forward-looking statements include statements regarding the intent, belief or current expectations of our management team as well as the assumptions on which such statements are based. Any forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could cause actual results to differ materially from any such statements including risks and uncertainties described in our most recent annual report on Form 10-K filed with the SEC as supplemented in our first quarter 10-Q. The company assumes no responsibility to update forward-looking statements. Management's remarks during this call also refer to certain non-GAAP measures. Reconciliations of the non-GAAP measures to the most comparable GAAP measures and explanations for their use are contained in the company's earnings release and Form 8-K furnished with the SEC today. Lastly, this call is being recorded and broadcasted for Interface. It contains copyrighted material and may not be rerecorded or rebroadcasted without Interface's expressed permission. Your participation on the call confirms your consent to the company's taping and broadcasting of it. After our prepared remarks, we will open up the call for questions. Now I will turn the call over to Laurel Hurd, CEO.

Thank you, Christine, and good morning, everyone. Interface delivered another strong quarter, exceeding our expectations with currency-neutral net sales growth of 4% and significant profitability gains. We saw continued strength in the Americas and increased momentum in EAAA with broad-based growth across all regions, all product categories, and the majority of our market segments. We are pleased with the quality of our earnings. Net sales increased through a balanced mix of price and volume and adjusted gross profit margin expanded by 208 basis points driven by favorable mix and manufacturing efficiencies. This consistent execution underscores the power of our diversified portfolio, the strength of our brand, and ongoing share gains in key markets. I'm proud of the Interface team and their unwavering commitment to serving our customers. Our One Interface strategy is driving these results. As we've discussed before, this multiyear plan is focused on building strong global functions to support our world-class local selling team, accelerating growth through enhanced commercial productivity, expanding margin through global supply chain management, simplifying operations, and leading in design, performance, and sustainability. Since launching our One Interface sales team structure in the U.S. in January 2024, we've been delivering a single cohesive customer experience across carpet tile, LVT, and Nora Rubber. This unified approach has exceeded our expectations and continues to drive consistent quarterly growth. Driven by our combined selling team, Nora Rubber grew 20% in the third quarter and is up 19% year-to-date. To build on this momentum, we will accelerate investments in automation, productivity, and innovation to further strengthen the Nora product portfolio and drive long-term growth. We're preparing for the launch of a new rubber flooring innovation in early 2026 that we believe will accelerate growth in the Healthcare segment, among others. We look forward to sharing more about this on our next call. Additionally, our investments in carpet tile automation and robotics are delivering meaningful productivity gains and margin improvement. These investments are exceeding expectations, improving efficiency, reducing waste, and enhancing service levels. We are now extending these robotic systems to our facilities in Europe and Australia, and we continue to explore and identify new opportunities for automation across the company. From a product standpoint, we continue to expand our addressable market, delivering high design at compelling price points to create new opportunities for growth. During the quarter, we introduced our stellar Horizon's carpet tile collection, which spans a range of price points and supports segment versatility. The collection offers exceptional durability, acoustics, and cleanability while balancing design and functional performance. We also introduced three new resilient products that expand color, design, and aesthetic options across the category. This includes two new LVT styles in the mix and raw materials and a refresh of our norament XP rubber offering. These new and updated styles give customers more ways to specify Interface products across a range of spaces and budgets. We continue to differentiate our portfolio through exceptional design, superior performance, and an unwavering commitment to sustainability. Now let's turn to our third quarter results. We delivered a 4% increase in currency-neutral net sales reflecting strong execution and continued share gains. In the Americas, currency-neutral net sales increased 4% as our combined selling teams drove growth across key market segments. In EAAA, currency-neutral net sales were also up 4% through broad-based growth in all our regions. Turning to market segments, our diversification strategy continues to fuel our growth. Global healthcare billings were up 29% with double-digit gains across both the Americas and EAAA. Our broad and differentiated product portfolio continues to capture opportunities as the global healthcare sector evolves, driven by an aging population, technological innovation, and a growing focus on preventative care. In the U.S., our combined Interface and Nora selling teams are working together seamlessly, enabling us to compete more effectively and win new opportunities as we meet the complex and changing needs of the modern healthcare environment. Corporate office billings were up 5% in the third quarter, and they are also up year-to-date as expected. We continue to see share gains in this segment as companies move to Class A space where our brand strength, design leadership, and broad product portfolio position us to win. Our solutions are well aligned with workplace trends as companies invest in refreshes and adapt environments to meet the evolving needs of a hybrid workforce. And by expanding our product offerings across a wider range of price points, we are capturing new opportunities and broadening our reach. Education billings declined slightly in the third quarter but remain up high single digits year-to-date. We view the slight quarterly decline as timing-related as we are well positioned in both K-12 and higher education underpinned by our design leadership and low-carbon high-performing products. Strong macro drivers, modernization initiatives, and regional migration continue to create meaningful growth opportunities in this segment. Turning to orders. Consolidated currency-neutral orders increased 2.4% year-over-year. Americas was up 1.7% on top of prior year order growth of 17.1%. EAAA was up 3.5%, driven by strength in EMEA and Australia. We ended the third quarter with our backlog up 17% year-to-date, reflecting solid underlying demand. Our strong results this quarter reflect how well our teams are delivering for our customers. That's evident in the recognition we received from the design community. Interface earned multiple #1 rankings in the Floor Focus top 250 design survey, where designers named us an industry leader in service, quality, design, and performance. On the sustainability front, we were named Manufacturer of the Year in Ed's Net Zero Awards and recognized by Metropolis in their Planet Positive Awards for our all-in strategy. These awards acknowledge the bold steps we are taking to be carbon-negative by 2040 without offsets, and they are a testament to the hard work and dedication of our entire team. Looking ahead, we remain confident in our strategy and disciplined execution. Continued investments in innovation, automation, and commercial excellence are strengthening our foundation for sustainable growth. With a talented global team, a powerful brand, and a proven strategy, Interface is well-positioned to deliver differentiated design, strong financial performance, and long-term value for our shareholders. With that, I'll turn it over to Bruce.

Well, thank you, Laurel, and good morning, everyone. Third quarter net sales were $364.5 million, up 5.9% as reported and 4.2% on a currency-neutral basis versus the third quarter of 2024, both ahead of our expectations. Third quarter currency-neutral net sales were up 4.1% in the Americas and 4.3% in EAAA year-over-year. Adjusted gross profit margin was 39.5%, up 208 basis points versus the third quarter of 2024, driven by favorable pricing and product mix combined with manufacturing efficiencies, partially offset by higher raw material and tariff-related costs. Adjusted SG&A expenses were $90 million in the third quarter compared to $85.5 million in the third quarter of 2024, primarily due to higher sales commissions and variable compensation on increased sales and profits, inflation, and foreign currency exchange variances. Adjusted operating income was $54.1 million, up 24.5% year-over-year. Third quarter adjusted EBITDA was $66.2 million versus $53.7 million in the third quarter of 2024. Third quarter adjusted earnings per share was $0.61, a 27% increase versus $0.48 in the third quarter of 2024. We generated $76.7 million of operating cash flow during the third quarter and ended the period with $482 million of liquidity. Net debt defined as total debt minus cash on hand was $120.4 million, and our net leverage ratio was 0.6x, calculated as net debt divided by the last 12 months of adjusted EBITDA. As part of our balanced capital allocation strategy, we repurchased $0.7 million of Interface common stock during the quarter. Overall, our strong balance sheet provides flexibility and optionality in today's dynamic environment and the ability to continue investing in the business for growth and margin expansion. Turning to tariffs. You may recall, our exposure is limited and primarily tied to imports of Nora Rubber from Germany and LVT from South Korea into the U.S. We continue to offset tariff-related costs through pricing and productivity initiatives. When tariff costs are successfully offset on a dollar-for-dollar basis, we are able to protect our gross profit dollars, but there is a dilutive impact to our gross profit percentage. In the third quarter, tariffs diluted our adjusted gross profit percentage by approximately 30 basis points, and we anticipate a similar dilution of 50 basis points in fourth quarter's adjusted gross profit percentage. In sum, we are successfully managing tariff-related costs, and our plan is to continue doing so. With that backdrop in mind and on the strength of our year-to-date results, we are raising our full-year guidance. For the full fiscal year of 2025, we now anticipate net sales of $1.375 billion to $1.390 billion, adjusted gross profit margin of 38.5% of net sales, adjusted SG&A expenses of $362 million, adjusted interest and other expenses of $25 million, and adjusted effective income tax rate of 26%, capital expenditures of $45 million, and fully diluted weighted average share count of 59.1 million shares. To note, all figures are approximate. And with that, I'll turn the call back to Laurel.

Thank you, Bruce. Interface delivered another strong quarter with growth in all product categories, growth in all regions, and growth in the majority of our market segments while driving meaningful gross profit margin expansion. We are encouraged by the quality of these earnings and the strong execution in a challenging and uncertain macro environment. I want to thank the entire Interface team for their relentless focus on winning business and serving our customers. With that, we will open up the call for questions.

Your first question today comes from Brian Biros from TRG.

Sales were above the guidance range, second quarter in a row of sales slightly above the guidance range. So clearly, something is working over there. Last quarter, you cited strong momentum, and education outperformed a tough comp. It sounds like this quarter, maybe it's health care that's the outperformer. So just curious to hear what the surprise was that drove the sales outperformance relative to your expectations three months ago.

Yes. Thanks, Brian. And it is health care. We noted health care was up 29% for the quarter, which is above our expectations. We've been really focused on the healthcare segment. Our top three priority segments are really corporate office, education, and health care. But we've been working to expand our product portfolio in health care. Obviously, the One Interface selling teams continue to exceed our expectations. And we grew in health care outside the U.S. as well. So really, really strong quarter that exceeded our expectations.

Brian, I would just also add, our One Interface selling teams are just executing so strongly. We just continue to upscale the organization, and we continue to see in our selling organization and our customer service organization, a relentless focus on winning for the customer and making sure we serve the customer and, importantly, making sure we win business and take share.

It's definitely working for you guys. On the Nora and the rubber I guess, further investments you mentioned in the prepared remarks. I know you're going to provide some more color, I guess, next call. But any more commentary you can add on the investments you might make there that's across expanding capacity or just more automation in the Nora facility, it would be interesting to hear.

Yes. We've been making investments all along in Nora, and we will continue to amplify that as our sales growth continues to exceed expectations. So we're doing a few things. One, we're investing in making sure we can support the capacity. Secondly, we are investing in additional productivity initiatives to increase our throughput and also to really help drive efficiencies, and then we're also investing in innovation. So that's what we'll share more about on our next call, but we're excited about continued opportunities to grow the Nora business.

Brian, I would just add, if we think about CapEx in 2026, it may be slightly up, potentially around $10 or so million compared to 2025 levels as we invest in these productivity initiatives in innovation projects. Again, it's all about growth. It's all about innovation and all about projects that generate margin expansion.

Last question for me on margins. Current guide for the year, it looks like it's 38.5%. It's been a nice step-up throughout the year to get there. I believe maybe the 38.5% level is also kind of the near-term margin level you might have cited in the past that you want to get to that kind of balances price with volume and cash generation. So if you're going to get at that level this year, how do we think about margins from here with all the positive things you still have between mix and efficiencies? Do we see further margin expansions from here? Or do you kind of keep it at this level to accelerate volumes even more? So just curious how you think about margins at this level and going forward.

Brian, thank you for noticing. As we've mentioned previously, our ambition is to get to 38.5%. And we got a good shot at hitting that number this year. To be fair, we have to deliver a strong Q4, which we intend to do, but it's a challenging dynamic environment and it's a balancing act between taking share, winning for our customers, and also making sure that we can hit that nice sweet spot between taking share and growing the business.

Your next question comes from the line of Alex Paris from Barrington Research.

I just wanted to say congratulations on the beat and raise.

Thanks, Alex.

I have a few questions. I'll start with one about the performance in Q3. How did the momentum shape up in terms of orders? Last time, you mentioned that July was strong and broad-based. How did August and September perform? Also, could you provide an update on October for the fourth quarter?

Yes, Alex, I would say it's been steady and consistent. The quarter performed consistently, and October has continued in that trend. The Americas look particularly strong. However, conditions outside the U.S., especially in Europe, are more challenging. We are monitoring the order momentum closely, but we feel optimistic about our guidance for Q4.

Yes, I agree. And Alex, our demand is solid. Our backlog is strong, and we just need to continue executing strongly.

Great. And then the market segment discussion, health care, up 29% in global billings, corporate office up 5%, great performance. As you said, education declined slightly. Can we put some numbers on that? I mean was it down 3%? Or was it down 8%?

Down less than 3%. So just down about 2.5% or so.

Alex, that’s just timing. Things come in uneven phases. It’s up high single digits for the year. We have a strong education business, excellent products, and good momentum. So it’s really just timing in the quarter.

And not a big quarter for education as well. Q2 is really education season for us. So not something we're concerned about.

Okay. Great. And then on the gross margin expansion, you kind of listed the things that influenced that. It was similar to last quarter, favorable price and volume as well as manufacturing efficiencies. I think you said last quarter that 80% of the gain was manufacturing efficiencies. Is it sort of a similar thing going on this quarter?

About half and half. So our manufacturing efficiencies have been working very, very well. And that drove about half of the margin expansion and the rest was a combination of price and mix.

Great. And then you had a very unusual tax rate in the quarter of 4.8%. How about a little color? And then your guidance for the full year, I know it's on an adjusted basis, is unchanged at 26%. So what special items were in the Q3?

Yes, thank you for pointing that out. We mentioned this in our press release. In July 2025, Germany introduced tax legislation that will reduce the corporate income tax rate by 1% each year from 2028 to 2032. As a result, we had to remeasure our deferred tax assets and liabilities, leading to a noncash increase in our interest expense of $10.4 million. This adjustment was purely an accounting requirement stemming from the changes in German legislation.

Okay. That makes sense. But again, you gave guidance of 26% on an adjusted tax basis. So you're adding a $10.4 million back to the tax expense on a nine-month basis to get to that. Because otherwise, it's like 18% for the full year.

Yes, two different numbers. There's a GAAP number, and then there's the adjusted number. So the 26% is our adjusted effective income tax rate that excludes that pickup related to the German tax legislation.

Great.

I appreciate your attention to detail. We have now completed the amortization, and you will no longer see it on the P&L. It will take its course.

Okay. Got you. So that is a typical add back to gross income to get to adjusted gross income. So there won't be any add back in Q4 and going forward?

That's right. But of course, there's always a wash, because there was the expense in net income. And so we won't see the expense in net income, and hence, we won't see the add back.

Your next question comes from the line of David MacGregor from Longbow Research.

Congratulations on the results. Just got a great trajectory going here.

Thanks, David.

I wanted to ask a few questions on different topics. Starting with the gross margins at 38.5%, if we account for tariffs, it's actually 30 basis points better. Regarding the potential for upside from this level, is it primarily driven by volume leverage and increasing your units going forward? Or is there a mix benefit related to healthcare and Nora that could be influencing that? I'm trying to understand the underlying factors contributing to any further upside from here.

Yes, thank you, David. As Bruce mentioned earlier, we aimed for 38.5% and we reached it sooner than anticipated, to be honest. This achievement is due to three main factors. First, the mix, particularly the strong performance in the U.S. and the growth of Nora Rubber sales there. Second, our productivity initiatives have exceeded expectations due to our investments. Lastly, there’s volume leverage as well. Looking ahead, I believe there’s still room for improvement in productivity. We will keep focusing on mix and volume leverage. At the same time, as Bruce noted, we’ll continue to explore ways to drive share growth and navigate the competitive market effectively, ensuring we find the right balance.

So if I could just sort of pick up on a couple of these things here. I don't know, operator, are there any other questions behind me in the queue?

No, there are not.

Okay. I have a few here for you, if you don't mind. I guess when you automate the front end of the manufacturing lines, it's obviously created a lot of productivity benefit, and now you're going to take those learnings and you're going to go to Europe and to Australia. If we isolate that, what could that represent in terms of gross margin upside?

Well, David, the U.S. represents a larger figure, but all these numbers are significant. We are investing in machinery and robotics, and the benefits have been notable, especially since we faced challenges in filling difficult positions. We're experiencing advantages such as reduced waste in our manufacturing plants, which positively impacts our inventory and sales costs. For instance, we are simply using fewer cones. Many small improvements are contributing to our success in the U.S., and we anticipate similar benefits in Australia and Europe. However, it's important to note that those markets are smaller compared to the U.S.

They are. But it sounds like when you talk about the three buckets mix, productivity, and volume leverage, the big part of that productivity bucket is this migration of what you've learned. And then on the volume leverage, we talked about sort of incremental margins right now. And I realize they're a little bit different from Nora versus LVT versus carpet tile and within carpet tile, you have various price points where you could get some variance in your operating leverage. But how should we be thinking about incremental margins and the potential upside from here on incremental margins?

I think the situation that we're in, David, is we are going to continue to be laser-focused on driving efficiencies in our manufacturing environment. It's just so important that we do that to maintain our competitiveness. And in a really challenging market to make sure that we have the right price points to meet our customers where they are so that we can continue driving volume and we can continue driving share.

The other thing, David, that we've been doing is we've talked about expanding our addressable market by pushing a bit more to accessible price points, particularly in carpet tile, and we've done that through design for manufacturing, making sure we maintain our efficiencies while we're doing that. But that's helping us drive growth. So we'll continue to do more of that as well and again, sort of manage that sweet spot.

Okay. So I mean, on the one hand, you get a little more Nora coming in here, you're making the capacity investments, we would presume that that becomes a stronger part of the mix. On the other hand, you've got more medium price point product rolling out. So should we just be thinking incremental margins kind of remaining in line with where they are right now? I guess I'm just looking for a little bit of help there.

We want to deliver this year. We got a great year, great nine months behind us. We got to deliver another three great months, and we'll have a solid year. And then if we do hit our ambition, and I think to be fair, David, I appreciate your question. I appreciate your probing. I think maybe when we release our year-end results, and we see how this all shakes out, we would be in a stronger position to talk about perhaps what is our next ambition around gross profit. But for right now, we just want to hit the current ambition.

Sure. You previously mentioned the addition of global product category management and possibly staffing someone in that role. This seems to tie into the One Interface program. Can you discuss the percentage of revenues and how it is changing with projects that involve multiple categories, particularly in both American and European markets? We're increasingly engaging in projects where we provide a full range of products to companies across these markets. I'm just trying to gauge this shift and whether it has an impact on your margins, so I'm looking for an understanding of the current proportion.

Yes. We have introduced global product category management, which will enhance our innovation pipeline moving forward. We anticipate new innovations next year that will be exciting. These innovations will be global launches, approached from a macro perspective, and we believe they will significantly help us expand our ability to offer our entire product portfolio to our customers. Instead of only providing specific products like Nora to health care or carpet tile to corporate offices, we are now presenting our complete range. Additionally, we have strong global customers, and we are now able to provide them with our full suite of products. This is still in the early stages, and we are committed to further developing this initiative as we progress.

Okay. That's helpful. And then, Bruce, you mentioned capital allocation up about $10 million next year in CapEx versus where you're going to be this year. Is that full $10 million associated with Nora or are there other programs?

A large portion of it is Nora, but there is innovation happening outside of Nora. And there are some automation investments happening outside of Nora as well.

Okay. And on capital allocation as well, you're buying back stock, which is a real milestone, I guess, for Interface. How do you think about sort of that program going forward? Is this kind of a residual? We don't have any other immediate use for the cash, so we buy back stock? Or are you sort of employing targets in mind with respect to what you want to accomplish on a repurchase level?

Yes, it's a strategic decision. However, we always prioritize investing in the business for growth, margin improvement, and innovation. We also ensure we are responsible stewards of the corporation and our capital allocation priorities. When opportunities arise, we aim to return capital to our shareholders.

Got it. Well, congratulations on all the progress. Great to see.

Thanks, David. Appreciate it.

And that concludes our question-and-answer session. I will now turn the call back over to Laurel Hurd for closing remarks.

Great. Thanks to everyone for joining the call today, and thanks to the entire Interface team for another great quarter.

This concludes today's conference call. Thank you for your participation. You may now disconnect.